Opportunistic CAC screening is now possible with ClearRead CT CAC and CARPL.AI by leveraging every ungated, non-contrast chest CT for cardiac risk assessment and early intervention. ClearRead CT CAC accurately detects, quantifies and reports an Agatston score and risk level. The normalization capabilities lend to high accuracy across CT systems for consistent results, regardless of the equipment used. In a clinical study, ClearRead CT CAC demonstrated high agreement with readers and gated CAC exams for an accurate result on ungated CTs.^*

Schedule a demo to learn more.

*ClearRead CT CAC FDA 510(k) Clinical Study Results, 2024.